A NEW HOPE FOR BODY CONTROL ?

Experts are rapidly focused on retatrutide, a novel treatment developed by Eli Lilly, as a potential step in weight management. Different than many earlier approaches, retatrutide is a twin-action agonist targeting both GLP-1 and GIP, chemicals that influence satiety and glucose balance. Prelimi